Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers shows strong order momentum; full-year growth expectations lowered and earnings forecast raised
New corporate headquarters in Erlangen
Press release

Siemens Healthineers shows strong order momentum; full-year growth expectations lowered and earnings forecast raised

Siemens Healthineers AG today announces its results for the third quarter of fiscal year 2026 ended June 30, 2026.
Published on July 31, 2026

Q3 Fiscal Year 2026

  • Outstanding equipment book-to-bill ratio of 1.27
  • Comparable revenue growth of 2.8% after a very strong prior-year quarter (7.6%)
  • Adjusted EBIT margin of 19.1%, tariff refunds had a positive effect in all segments
  • Imaging comparable revenue growth of 2.3%; adjusted EBIT margin of 26.5%
  • Precision Therapy comparable revenue growth of 9.2%; adjusted EBIT margin of 17.5%
  • Diagnostics comparable revenue decline of 5.5%; adjusted EBIT margin of 4.1%
  • Adjusted basic earnings per share of €0.70, tariff refunds had a positive effect
  • Very high free cash flow of €1.0 billion, supported further by tariff refunds

Updated Outlook for Fiscal Year 2026

Primarily as a result of the performance of the Diagnostics segment in terms of revenue as well as the impact of refunds of tariffs imposed under the U.S. International Emergency Economic Powers Act (IEEPA) on adjusted basic earnings per share, we update our outlook for fiscal year 2026.

For fiscal year 2026, we now expect comparable revenue growth between 3.5% and 4.0% over fiscal year 2025 (previously between 4.5% and 5.0%). For adjusted basic earnings per share, we now expect a range of between €2.35 and €2.45 (previously between €2.20 and €2.30).

Bernd Montag, CEO of Siemens Healthineers AG:

”We showed great order momentum. Our synergetic core was robust on both top and bottom lines. Due to the revenue weakness in Diagnostics we are decreasing our revenue growth outlook while raising the EPS outlook by the amount of the tariff refunds.“

Download Quarterly Statement(pdf, 267.57 KB)

Siemens Healthineers 2026

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2025, which ended on September 30, 2025, Siemens Healthineers had approximately 74,000 employees worldwide and generated revenue of around €23.4 billion. Further information is available at siemens-healthineers.com.